Pharma-Bio Serv PBSV

OTC PBSV
$0.50 +0.08 (+19.05%)
At close: Nov 9, 2026 · 4:00 PM EST

Pharma-Bio Serv (PBSV) stock price is $0.50, up 19.05% on the day, as of Nov 9, 2026. It has a market cap of $11.45Mn and a P/E ratio of 45.53, and is classified in the Consulting industry (Industrials sector).

Key Stats
Market Cap11.45 Mn
P/E45.53
FCF (Yr)-221,530.00
ROA (Yr)-4.26
EV to EBIT174.34
Net Income (Yr)100,463.00
Enterprise Value-27.01 Mn
Add ratio to table…

About

Pharma-Bio Serv, Inc. is a Delaware corporation organized on January 14 2004 and provides technical compliance consulting services to the pharmaceutical chemical biotechnology medical devices cosmetic and food industries and allied products companies in Puerto Rico the United States Europe and Brazil. The firm operates as a regulatory affairs quality compliance and technology transfer services consulting firm with headquarters in Puerto Rico serving clients across multiple…

Read more ↓
Sectors: Industrials Healthcare Sector rationale The company's primary revenue model is based on providing technical compliance consulting, engineering project management, and process support to a broad range of industrial clients, including chemical, cosmetic, and food industries. While it heavily serves the life sciences sector (pharmaceuticals, biotech, and medical devices), which justifies a secondary sector in Healthcare, the core activity of 'technical compliance consulting' and 'engineering' for diverse manufacturing clients falls under the Industrials sector's consulting and business-facing services. Industries: Consulting Consulting Primary Pharma-Bio Serv is a consulting firm that sells professional expertise in regulatory affairs, quality compliance, and technology transfer. Its revenue is primarily generated through time and materials contracts for providing technical compliance consulting to businesses in the pharmaceutical, biotechnology, and medical device industries. Contract Research Contract Research Secondary The company provides validation, regulatory compliance, and process support services to pharmaceutical and biotechnology companies, which are core activities of contract research and development outsourcing for drug and device sponsors. Classified using BQ-MICS CIK: 0001304161

Statement Geographical Axis Breakdown of Revenue (2025)

History
Peer percentiles

How Pharma-Bio Serv ranks

Ranked against the 131 companies in Business Services58 metrics · as of Nov 6, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/E 47.3xMedian 21.1x 53rd
  • P/FCFNegative free cash flow −28.3xMedian 15.3x 23rd
  • P/Operating cash flowNegative operating cash flow −28.7xMedian 11.9x 14th
  • P/S 1.26xMedian 0.90x 38th
  • P/B 1.14xMedian 2.27x 65th
  • P/Tangible book 1.14xMedian 3.04x 71st
  • EV/EBITDANegative EBITDA −34.3xMedian 11.7x 16th
  • EV/EBITNegative EBIT −21.5xMedian 17.6x 23rd
  • EV/Revenue 0.35xMedian 1.17x 88th
  • EV/FCFNegative free cash flow −7.91xMedian 17.8x 8th
  • EV/Operating cash flowNegative operating cash flow −8.03xMedian 14.4x 7th
  • PEG (3Y EPS CAGR)EPS is not growing −1.05Median 0.88 Not meaningful —
Peer group

Peer Comparison

Companies in the Consulting
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 ACN Accenture plc 156.49 Bn18.702.1110.11 Bn
2 CTAS Cintas Corp 89.36 Bn43.377.732.43 Bn
3 IRM Iron Mountain Inc 33.13 Bn72.264.2517.97 Bn
4 ROL Rollins Inc 18.53 Bn35.234.650.73 Bn
5 APG APi Group Corp 18.33 Bn-79.712.063.57 Bn
6 ULS UL Solutions Inc. 16.46 Bn32.085.170.76 Bn
7 ARMK Aramark 14.43 Bn37.680.736.13 Bn
8 PBSV Pharma-Bio Serv, Inc. 0.01 Bn45.531.21-